Natick-based Boston Scientific Corp. has acquired Irish coronary stent company Labcoat Limited.
Labcoat is a private company that has developed a drug-eluting stent that uses droplets of a biodegradable polymer combined with drugs to create a thin coating on the outside of the stent.
Boston Scientific said it has had an ongoing relationship with Galway-based Labcoat. Financial terms of the acquisition were not disclosed.
Labcoat successfully completed a clinical trial of a Boston Scientific stent, a tiny metal framework that props open damaged blood vessels, coated with the Labcoat polymer and drug combination.
